Skip to content
healthcare.dev
Get a free key

deferasirox

NDC 68462-495, deferasirox, tablet, for suspension, from Glenmark Pharmaceuticals Inc., USA.

Product NDC
68462-495
Status
Listed
Labeler
Glenmark Pharmaceuticals Inc., USA
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209433
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68462-495 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX250 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
68462-495-906846204959090 TABLET, FOR SUSPENSION in 1 BOTTLE (68462-495-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/59f1d3fb-5bdb-4261-8557-9a4bde8b3c1c

Use it

Look up 68462-495 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68462-495 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68462-495. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.